Terms: = Gastric cancer AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3 AND Treatment
12 results:
1. Management of type 1 gastric neuroendocrine tumors: an 11-year retrospective single-center study.
Chen YY; Guo WJ; Shi YF; Su F; Yu FH; Chen RA; Wang C; Liu JX; Luo J; Tan HY
BMC Gastroenterol; 2023 Dec; 23(1):440. PubMed ID: 38097952
[TBL] [Abstract] [Full Text] [Related]
2. Clinicopathological Features and Prognosis of Gastrointestinal Metastases From Breast Carcinoma: A Clinicopathological Study of 22 Patients.
Wang S; Li W; Li S; Liu X; Zhang L; Hao C; Meng W; Zhao W; Tong Z
Int J Surg Pathol; 2023 Sep; 31(6):1075-1084. PubMed ID: 36803140
[No Abstract] [Full Text] [Related]
3. Combined use of single-balloon enteroscope and colonoscope for self-expandable metal stent placement in patients with malignant small intestinal obstruction: a single-center comparative clinical observation.
Zhang YF; Ning SB; Li BR; Zhang J; Li J; Tang J; Zhu M; Jin XW; Zhao Q; Mao GP
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):357-361. PubMed ID: 28585148
[TBL] [Abstract] [Full Text] [Related]
4. WIN 55,212-2 Inhibits the Epithelial Mesenchymal Transition of gastric cancer Cells via COX-2 Signals.
Xian X; Huang L; Zhang B; Wu C; Cui J; Wang Z
Cell Physiol Biochem; 2016; 39(6):2149-2157. PubMed ID: 27802436
[TBL] [Abstract] [Full Text] [Related]
5. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
[TBL] [Abstract] [Full Text] [Related]
6. Target therapy of unresectable or metastatic dermatofibrosarcoma protuberans with imatinib mesylate: an analysis on 22 Chinese patients.
Wang C; Luo Z; Chen J; Zheng B; Zhang R; Chen Y; Shi Y
Medicine (Baltimore); 2015 May; 94(17):e773. PubMed ID: 25929918
[TBL] [Abstract] [Full Text] [Related]
7. Antineoplastic effect of WIN 55,212-2, a cannabinoid agonist, in a murine xenograft model of gastric cancer.
Oh JH; Lee JY; Baeg MK; Han KH; Choi MG; Park JM
Chemotherapy; 2013; 59(3):200-6. PubMed ID: 24335109
[TBL] [Abstract] [Full Text] [Related]
8. Cannabinoid receptor agonist as an alternative drug in 5-fluorouracil-resistant gastric cancer cells.
Xian XS; Park H; Choi MG; Park JM
Anticancer Res; 2013 Jun; 33(6):2541-7. PubMed ID: 23749906
[TBL] [Abstract] [Full Text] [Related]
9. Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells.
Park JM; Xian XS; Choi MG; Park H; Cho YK; Lee IS; Kim SW; Chung IS
J Cell Biochem; 2011 Apr; 112(4):1192-205. PubMed ID: 21312237
[TBL] [Abstract] [Full Text] [Related]
10. Effect of a synthetic cannabinoid agonist on the proliferation and invasion of gastric cancer cells.
Xian XS; Park H; Cho YK; Lee IS; Kim SW; Choi MG; Chung IS; Han KH; Park JM
J Cell Biochem; 2010 May; 110(2):321-32. PubMed ID: 20336665
[TBL] [Abstract] [Full Text] [Related]
11. SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells.
Takahata M; Inoue Y; Tsuda H; Imoto I; Koinuma D; Hayashi M; Ichikura T; Yamori T; Nagasaki K; Yoshida M; Matsuoka M; Morishita K; Yuki K; Hanyu A; Miyazawa K; Inazawa J; Miyazono K; Imamura T
J Biol Chem; 2009 Jan; 284(5):3334-3344. PubMed ID: 19049980
[TBL] [Abstract] [Full Text] [Related]
12. Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
Malfertheiner P; Mégraud F; O'Morain C; Hungin AP; Jones R; Axon A; Graham DY; Tytgat G;
Aliment Pharmacol Ther; 2002 Feb; 16(2):167-80. PubMed ID: 11860399
[TBL] [Abstract] [Full Text] [Related]
